← board
SION
Sionna Therapeutics Inc.distress 3/10 · well-funded / low risk$44.37-1%today-10% from 52w high
Respiratory 2
Lead: cystic fibrosis · est. market ~$10B (approx, global)
Revenue
pre-revenue
Liquidity
$63M
Runway
0.9 yrs
Shares 1y
+2%
Price & events
+6.2% over 6M
CatalystRating changeDilutionFinancingdashed = today
-1.5%
1D
-2.0%
1W
+11.3%
1M
+15.7%
3M
+4.7%
6M
+124.4%
1Y
—
2Y
—
5Y
+77.5%
All
Overview
- Market Cap
- $2.00B
- Volume
- 58.77K
- 52 Week Range
- $16.74 – $49.41
- Total Shares
- 45.15M
- Float Shares
- 16.76M
- Short %
- 19.86%
- % Held by Insiders
- 6.85%
- % Held by Institutions
- 100.03%
- RVOL
- 0.11x
Pipeline stages · 1 programs
SION-719
Preclin›
Ph1›
Ph2›
Ph3›
Filed›
PDUFA›
Approved
Pipeline · 2 trials · 0 upcoming
| Readout | Phase | Drug | Indication | Enroll | Status |
|---|---|---|---|---|---|
| 2026-07 | Phase 2 | SION-719 | Cystic Fibrosis (CF) | 16 | active not recruiting |
| 2026-06 | Phase 1 | SION-451, SION-2222, SION-109 | Cystic Fibrosis (CF) | 144 | recruiting |
Catalyst news & presentations · 3
- 2026-08-10Estimated 45%earningsEarningsEarnings releaseyahoo
- mid-2026readoutPhase 2SION-719 · Topline data from Phase 2a trialSEC 8-K
- second half of 2025trial initiationsecondaryPhase 1SION-451 · Phase 1 healthy volunteer dual combination trial with complementary modulatorsSEC 8-K
Approved drugs (0)
- none — clinical-stage
Capital structure — dilution & financing
🔒 Top holders — Pro
Institutional ownership + quarter-over-quarter accumulation/trimming.
Upgrade to ProWall St ratings
buy · target $52 (+16% upside) · 10 analysts
- 2026-05-26CitizensMarket Outperform
- 2026-05-20Freedom BrokerBuy → Hold
- 2026-05-18StifelBuy
- 2026-05-13BTIGBuy
- 2026-05-05WedbushOutperform
- 2026-04-28Jones TradingBuy
Competitors — cystic fibrosis
Recent news
- 2026-07-23Sionna Therapeutics Slides as Lofty Valuation Deflates - TipRanks
- 2026-07-20Sionna Therapeutics Inc. (SION) Stock Price | Live Quotes & Charts | NASDAQ - timothysykes.com
- 2026-07-195 Undervalued Stocks That Soared: SION +277%, FBRX +306%, NKTR +869% & More - RTTNews
- 2026-07-18SION Jumps As Sionna Therapeutics Stock Extends Breakout - StocksToTrade
- 2026-07-18SION Jumps As Sionna Therapeutics Draws Trader Attention - StocksToTrade
- 2026-07-17Sionna Therapeutics stock hits all-time high at 48.66 USD - Investing.com UK
- 2026-07-17Sionna Therapeutics stock hits all-time high at 48.66 USD - Investing.com
- 2026-07-17Sionna Therapeutics Surges As CF Trial Data Loom - TipRanks
Not financial advice. Data: ClinicalTrials.gov, SEC EDGAR, FINRA, Nasdaq, Yahoo.